A new DNA-based vaccine for Type 1 diabetes in an early stage trial has shown that it has the potential to stall the manifestation of the disease, and even to prevent the disease from manifesting entirely.
A person with Type 1 diabetes has an immune system that attacks the cells in his or her pancreas that produce insulin; people require insulin to regulate blood sugar. The interesting facet of this DNA-based vaccine is that it does not enhance the immune system, but rather suppresses the part of the immune system that stops insulin production. Researchers find the result of the trial exciting because it suggests that shutting down one subset of dysfunctional immune cells is possible. Read more here.